Header Logo

Connection

REYNOLDS DELGADO to Humans

Back to Details
This is a "connection" page, showing publications REYNOLDS DELGADO has written about Humans.
REYNOLDS DELGADO
Connection Strength
0.239
Humans
  1. Factor Xa inhibitors in patients with continuous-flow left ventricular assist devices. Gen Thorac Cardiovasc Surg. 2020 Nov; 68(11):1278-1284.
    View in: PubMed
    Score: 0.015
  2. Direct thrombolytic therapy for thrombosis of a centrifugal flow left ventricular assist device. ASAIO J. 2013 Sep-Oct; 59(5):530-2.
    View in: PubMed
    Score: 0.009
  3. Bivalirudin for treatment of aortic valve thrombosis after left ventricular assist device implantation. ASAIO J. 2013 Jul-Aug; 59(4):448-9.
    View in: PubMed
    Score: 0.009
  4. Transcatheter aortic valve replacement in a nonagenarian. Tex Heart Inst J. 2013; 40(2):196-7.
    View in: PubMed
    Score: 0.009
  5. Weight loss caused by visceral artery disease. Tex Heart Inst J. 2013; 40(3):320-2.
    View in: PubMed
    Score: 0.009
  6. PleurX catheter for the management of refractory pleural effusions in congestive heart failure. Tex Heart Inst J. 2009; 36(1):38-43.
    View in: PubMed
    Score: 0.007
  7. Devices for heart failure: the future is now. Congest Heart Fail. 2008 May-Jun; 14(3):141-8.
    View in: PubMed
    Score: 0.006
  8. Symptomatic relief: left ventricular assist devices versus resynchronization therapy. Heart Fail Clin. 2007 Jul; 3(3):259-65.
    View in: PubMed
    Score: 0.006
  9. The financial burden of destination left ventricular assist device therapy: who and when? Curr Cardiol Rep. 2007 May; 9(3):194-9.
    View in: PubMed
    Score: 0.006
  10. The effect of administering erythropoiesis-stimulating proteins in patients with chronic heart failure: results from a retrospective study. Congest Heart Fail. 2006 Nov-Dec; 12(6):297-301.
    View in: PubMed
    Score: 0.006
  11. Brain natriuretic peptide levels and response to cardiac resynchronization therapy in heart failure patients. Congest Heart Fail. 2006 Sep-Oct; 12(5):250-3.
    View in: PubMed
    Score: 0.006
  12. Clinical experience with the TandemHeart percutaneous ventricular assist device. Tex Heart Inst J. 2006; 33(2):111-5.
    View in: PubMed
    Score: 0.005
  13. Unprotected left main stent placement in a patient with Takayasu's arteritis: an unusual solution for an unusual disease. Tex Heart Inst J. 2006; 33(2):253-5.
    View in: PubMed
    Score: 0.005
  14. Catheterization of the AbioCor implantable replacement heart: evaluation of the unique physiology created by the device. Tex Heart Inst J. 2006; 33(3):359-60.
    View in: PubMed
    Score: 0.005
  15. Increased cost effectiveness with nesiritide vs. milrinone or dobutamine in the treatment of acute decompensated heart failure. Congest Heart Fail. 2005 Nov-Dec; 11(6):311-4.
    View in: PubMed
    Score: 0.005
  16. HeartMate II left ventricular assist device: a new device for advanced heart failure. Expert Rev Med Devices. 2005 Sep; 2(5):529-32.
    View in: PubMed
    Score: 0.005
  17. Role of B-type natriuretic peptide and effect of nesiritide after total cardiac replacement with the AbioCor total artificial heart. J Heart Lung Transplant. 2005 Aug; 24(8):1166-70.
    View in: PubMed
    Score: 0.005
  18. West Nile virus infection after cardiac transplantation. J Heart Lung Transplant. 2005 Jun; 24(6):774-6.
    View in: PubMed
    Score: 0.005
  19. Direct thrombolytic therapy for intraventricular thrombosis in patients with the Jarvik 2000 left ventricular assist device. J Heart Lung Transplant. 2005 Feb; 24(2):231-3.
    View in: PubMed
    Score: 0.005
  20. Management of acute and chronic heart failure with left ventricular assist devices. Am Heart Hosp J. 2005; 3(3):153-60.
    View in: PubMed
    Score: 0.005
  21. Intravenous milrinone infusion improves congestive heart failure caused by diastolic dysfunction: a brief case series. Tex Heart Inst J. 2005; 32(2):220-3.
    View in: PubMed
    Score: 0.005
  22. Use of the Flowmaker (Jarvik 2000) left ventricular assist device for destination therapy and bridging to transplantation. Cardiology. 2004; 101(1-3):111-6.
    View in: PubMed
    Score: 0.005
  23. Hemodynamic support with a percutaneous left ventricular assist device during stenting of an unprotected left main coronary artery. Tex Heart Inst J. 2004; 31(1):84-6.
    View in: PubMed
    Score: 0.005
  24. Mechanical circulatory support for advanced heart failure: where does it stand in 2003? Circulation. 2003 Dec 23; 108(25):3064-8.
    View in: PubMed
    Score: 0.005
  25. The future of mechanical circulatory support. Curr Opin Cardiol. 2003 May; 18(3):199-209.
    View in: PubMed
    Score: 0.004
  26. Intravenous milrinone in treatment of advanced congestive heart failure. Tex Heart Inst J. 2003; 30(2):109-13.
    View in: PubMed
    Score: 0.004
  27. Continuous-Flow Left Ventricular Assist Device Support in Patients with Ischemic Versus Nonischemic Cardiomyopathy. Tex Heart Inst J. 2021 Sep 01; 48(4).
    View in: PubMed
    Score: 0.004
  28. Ten-Year Survival With a Continuous-Flow Left Ventricular Assist Device and Aortic Valve Closure. Tex Heart Inst J. 2020 08 01; 47(4):325-328.
    View in: PubMed
    Score: 0.004
  29. Accuracy of Postoperative Risk Scores for Survival Prediction in Interagency Registry for Mechanically Assisted Circulatory Support Profile 1 Continuous-Flow Left Ventricular Assist Device Recipients. ASAIO J. 2020 05; 66(5):539-546.
    View in: PubMed
    Score: 0.004
  30. Outcomes of Repeat Left Ventricular Assist Device Exchange. ASAIO J. 2020 01; 66(1):64-68.
    View in: PubMed
    Score: 0.004
  31. Plasmapheresis in Patients With Heparin-induced Thrombocytopenia Requiring Ventricular Assist Device. Ann Thorac Surg. 2020 06; 109(6):e439-e440.
    View in: PubMed
    Score: 0.004
  32. Acute kidney injury after implantation of a left ventricular assist device: a comparison of axial-flow (HeartMate II) and centrifugal-flow (HeartWare HVAD) devices. J Artif Organs. 2018 Sep; 21(3):285-292.
    View in: PubMed
    Score: 0.003
  33. Improved systemic saturation after ventricular assist device implantation in a patient with decompensated dextro-transposition of the great arteries after the Fontan procedure. Tex Heart Inst J. 2015 Feb; 42(1):40-3.
    View in: PubMed
    Score: 0.003
  34. Circular air-filled space in the aortic knob: a rare radiologic finding. Tex Heart Inst J. 2014 Oct; 41(5):560-1.
    View in: PubMed
    Score: 0.002
  35. Association between cell-derived microparticles and adverse events in patients with nonpulsatile left ventricular assist devices. J Heart Lung Transplant. 2014 May; 33(5):470-7.
    View in: PubMed
    Score: 0.002
  36. Adenocarcinoma of the parotid gland metastatic to the ventricular septum and right ventricular wall. Tex Heart Inst J. 2012; 39(2):258-60.
    View in: PubMed
    Score: 0.002
  37. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant. 2010 Aug; 29(8):914-56.
    View in: PubMed
    Score: 0.002
  38. Accuracy of advanced versus strictly conventional 12-lead ECG for detection and screening of coronary artery disease, left ventricular hypertrophy and left ventricular systolic dysfunction. BMC Cardiovasc Disord. 2010 Jun 16; 10:28.
    View in: PubMed
    Score: 0.002
  39. Snake heart: a case of atavism in a human being. Tex Heart Inst J. 2010; 37(6):687-90.
    View in: PubMed
    Score: 0.002
  40. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009 Dec 03; 361(23):2241-51.
    View in: PubMed
    Score: 0.002
  41. Significance of anaemia in patients with advanced heart failure receiving long-term mechanical circulatory support. Eur J Heart Fail. 2009 Oct; 11(10):1000-4.
    View in: PubMed
    Score: 0.002
  42. The value of cardiac magnetic resonance imaging in the diagnosis of isolated non-compaction of the left ventricle. Isr Med Assoc J. 2009 May; 11(5):313-4.
    View in: PubMed
    Score: 0.002
  43. Effects of continuous aortic flow augmentation in patients with exacerbation of heart failure inadequately responsive to medical therapy: results of the Multicenter Trial of the Orqis Medical Cancion System for the Enhanced Treatment of Heart Failure Unresponsive to Medical Therapy (MOMENTUM). Circulation. 2008 Sep 16; 118(12):1241-9.
    View in: PubMed
    Score: 0.002
  44. Use of the percutaneous left ventricular assist device in patients with severe refractory cardiogenic shock as a bridge to long-term left ventricular assist device implantation. J Heart Lung Transplant. 2008 Jan; 27(1):106-11.
    View in: PubMed
    Score: 0.002
  45. Devices in heart failure: potential methods for device-based monitoring of congestive heart failure. Tex Heart Inst J. 2008; 35(2):166-73.
    View in: PubMed
    Score: 0.002
  46. Rationale, design, and methods for a pivotal randomized clinical trial of continuous aortic flow augmentation in patients with exacerbation of heart failure: the MOMENTUM trial. J Card Fail. 2007 Nov; 13(9):715-21.
    View in: PubMed
    Score: 0.002
  47. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007 Aug 30; 357(9):885-96.
    View in: PubMed
    Score: 0.002
  48. Usefulness of percutaneous left ventricular assist device as a bridge to recovery from myocarditis. Am J Cardiol. 2007 Jun 15; 99(12):1755-6.
    View in: PubMed
    Score: 0.001
  49. Is native aortic valve commissural fusion in patients with long-term left ventricular assist devices associated with clinically important aortic insufficiency? J Heart Lung Transplant. 2006 Apr; 25(4):395-9.
    View in: PubMed
    Score: 0.001
  50. Myocardial perfusion as assessed by positron emission tomography during long-term mechanical circulatory support. Congest Heart Fail. 2006 Mar-Apr; 12(2):69-74.
    View in: PubMed
    Score: 0.001
  51. Peripheral vascular reactivity in patients with pulsatile vs axial flow left ventricular assist device support. J Heart Lung Transplant. 2006 Apr; 25(4):391-4.
    View in: PubMed
    Score: 0.001
  52. Recovery from multi-organ failure in a patient with a continuous-flow left ventricular assist device. J Heart Lung Transplant. 2006 Jan; 25(1):148.
    View in: PubMed
    Score: 0.001
  53. Recovery from multi-organ failure in a patient with a continuous-flow left ventricular assist device. J Heart Lung Transplant. 2005 Aug; 24(8):1128-9.
    View in: PubMed
    Score: 0.001
  54. Antiphospholipid syndrome with anti-prothrombin autoantibodies in a patient with an axial-flow left ventricular assist device. J Heart Lung Transplant. 2005 Aug; 24(8):1133-6.
    View in: PubMed
    Score: 0.001
  55. Vascular thrombosis during support with continuous flow ventricular assist devices: correlation with computerized flow simulations. Congest Heart Fail. 2005 Jul-Aug; 11(4):182-7.
    View in: PubMed
    Score: 0.001
  56. Long-term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH study. Congest Heart Fail. 2005 May-Jun; 11(3):133-8.
    View in: PubMed
    Score: 0.001
  57. Images in cardiovascular medicine. High left ventricular assist device flows resulting from combined native aortic valve and outflow valve regurgitation. Circulation. 2005 Feb 01; 111(4):e34.
    View in: PubMed
    Score: 0.001
  58. Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist device. J Heart Lung Transplant. 2005 Jan; 24(1):105-9.
    View in: PubMed
    Score: 0.001
  59. The effect of LVAD aortic outflow-graft placement on hemodynamics and flow: Implantation technique and computer flow modeling. Tex Heart Inst J. 2005; 32(3):294-8.
    View in: PubMed
    Score: 0.001
  60. A successful anticoagulation protocol for the first HeartMate II implantation in the United States. Tex Heart Inst J. 2005; 32(3):399-401.
    View in: PubMed
    Score: 0.001
  61. Posttransplant off-pump coronary bypass and laser revascularization in a Jehovah's Witness. Tex Heart Inst J. 2005; 32(3):434-6.
    View in: PubMed
    Score: 0.001
  62. Quality of life in bridge-to-transplant patients with chronic heart failure after implantation of an axial flow ventricular assist device. Congest Heart Fail. 2004 Sep-Oct; 10(5):226-9.
    View in: PubMed
    Score: 0.001
  63. Jarvik 2000 FlowMaker axial-flow left ventricular assist device support for management of refractory ventricular arrhythmias. Congest Heart Fail. 2004 Jul-Aug; 10(4):195-6.
    View in: PubMed
    Score: 0.001
  64. Mechanical bridging to improvement in severe acute "nonischemic, nonmyocarditis" heart failure. Congest Heart Fail. 2004 Mar-Apr; 10(2):109-13.
    View in: PubMed
    Score: 0.001
  65. First clinical use of the redesigned HeartMate II left ventricular assist system in the United States: a case report. Tex Heart Inst J. 2004; 31(2):157-9.
    View in: PubMed
    Score: 0.001
  66. Continuous axial-flow left ventricular assist device (Jarvik 2000) maintains kidney and liver perfusion for up to 6 months. Ann Thorac Surg. 2003 Oct; 76(4):1167-70.
    View in: PubMed
    Score: 0.001
  67. Orthotopic cardiac transplantation 30 months after successful dynamic cardiomyoplasty. Ann Thorac Surg. 2003 Oct; 76(4):1289-91.
    View in: PubMed
    Score: 0.001
  68. Prolonged QTc interval and high B-type natriuretic peptide levels together predict mortality in patients with advanced heart failure. Circulation. 2003 Apr 08; 107(13):1764-9.
    View in: PubMed
    Score: 0.001
  69. Dobutamine stress echocardiography predicts myocardial improvement in patients supported by left ventricular assist devices (LVADs): hemodynamic and histologic evidence of improvement before LVAD explantation. J Heart Lung Transplant. 2003 Feb; 22(2):137-46.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.